Moberg Pharma — Major Shareholding Notification 2019

Feb 21, 2019

Issuer Moberg Pharma AB (publ)

Holder

Armistice Capital LLC (Delaware US LLC)

Instrument

Instrument	Shares SE0003613090
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	15/02/2019
Limit for number of shares	10 %
Limit for number of votes	10 %
After the transaction
Quantity
Shares	1,760,845
Directly held voting rights	0
Indirectly held voting rights	1,760,845
Percentage
Directly held shares	9.94616 %
Directly held voting rights	0 %
Indirectly held voting rights	9.94616 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	9.94616 %	1,760,845
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	9.94616 %	1,760,845
Chain of controlling companies Voting rights % Voting rights Company 1,760,845 9.94616 Armistice Capital Master Fund Ltd.
Group total holdings Voting rights 1,760,845 Percentage of voting rights 9.94616
Published 21/02/2019 08:58

Contact

Name Steve Chen

Phone +1 (212) 231-4937 Email schen@armisticecapital.com

*Source of information has chosen not to submit the data

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25